Medical Weight Loss for Renton, Washington Residents

Renton, Washington residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Renton through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Renton? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in Washington. Doctor review just $119 (medication separate).

Why Renton Residents Choose New Hope Weight Loss

A lot of clinics talk about supervision in the abstract. We can name the person doing it. Dr. Anjmun Sharma, MD oversees every Renton case personally, which means your dose, your check-ins, and your safety calls are decisions a single physician owns from start to finish. Compounded GLP-1 medication deserves that kind of continuity, and we would rather give you one accountable doctor than a queue of interchangeable ones.

If you are searching for medical weight loss in Renton, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

There is no New Hope Weight Loss office in Renton, and there does not need to be, since the same doctor-led program is delivered to every corner of Washington through telehealth visits. We care for patients throughout Downtown and the greater south Lake Washington area in metro Seattle. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Renton you are.

There are no local-office hours to fit your life around, so Renton patients can meet Dr. Sharma on evenings or between work without crossing town. The $119 fee covers the physician review and visit itself; the medication, whether semaglutide from $166 a month or tirzepatide from $233, is a separate charge. From the Puget Sound cities to the eastern plains of Washington, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Renton telehealth patients.

How Telehealth Works for Renton

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Renton address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Renton

Is New Hope Weight Loss available to Renton without a local branch?

Yes, even though we have no branch in Renton. Our one physical clinic is in Costa Mesa, California, and we reach Renton, Washington through telehealth. A secure video consult with Dr. Anjmun Sharma is where your medical history is reviewed and your fit for a compounded GLP-1 plan is confirmed.

From Renton, can I avoid traveling for appointments?

You can skip travel entirely. The program is built around telehealth, so Renton patients meet the doctor online, complete intake digitally, and stay connected by message. If approved, medication ships to your Renton home in cold-pack packaging that maintains a safe temperature on the way.

What will Renton patients spend on the program?

Expect $119 for the physician visit. Compounded semaglutide is offered from $166 per month or $499 for 90 days, and tirzepatide from $233 per month. The medication is billed separately. HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge for Renton residents at all.

What areas of Renton do you serve?

We serve patients from across Renton by telehealth, including Downtown and the greater south Lake Washington area in metro Seattle.

Who qualifies for the program in Renton?

Eligibility for Renton patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Renton Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Renton, Washington by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.